Clinical Edge Journal Scan

Vitamin D supplementation may reduce negative symptoms of MDD


 

Key clinical point: Vitamin D supplementation may reduce negative emotions in patients with major depressive disorder (MDD).

Major finding: Vitamin D supplementation reduced negative emotions at doses of ≤4,000 IU/day (Hedges' g = −0.2311; P = .0008). In the sub-group analysis, the effects were significant in patients with serum levels of 25(OH)D ≤50 nmol/L ( P = .0028), but not in those with levels >50 nmol/L ( P = .0507).

Study details: Systematic review and meta-analysis of 25 randomized controlled trials (n = 7,534) comparing the effects of vitamin D and the placebo on negative emotions in patients with MDD.

Disclosures: No funding information was identified. The authors declared no conflicts of interest.

Citation: Cheng YC et al. Depress Anxiety. 2020 May 04. doi: 10.1002/da.23025.

Recommended Reading

How can we better engage black men as patients?
MDedge Psychiatry
Ringing the alarm about black youth suicide
MDedge Psychiatry
Psychiatric manifestations of sport-related concussion
MDedge Psychiatry
‘Nietzsche was wrong’: Past stressors do not create psychological resilience.
MDedge Psychiatry
Beefed up inpatient/outpatient care transition is key to suicide prevention
MDedge Psychiatry
Meditations in an emergency: Talking through pandemic anxiety with a pioneer of mind-body medicine
MDedge Psychiatry
International medical graduates facing challenges amid COVID-19
MDedge Psychiatry
Helping families understand internalized racism
MDedge Psychiatry
Repetitive hits to the head tied to depression, poor cognition in later life
MDedge Psychiatry
MDD: Verbal learning deficit may be a potential marker for suicide risk
MDedge Psychiatry